About us
Our Story
Leadership
Board of Directors
Scientific Advisory Board
Our Products
Sibnayal®
Other Products
R&D
Disease Focus Area
Distal Renal Tubular Acidosis (dRTA)
Cystinuria
Investors
Investor Relations
Management Team
Press Releases
Events & Presentations
Analyst Coverage
Stock Information
Financial Information
Investors FAQs
Contact Us
EN
FR
Advicenne France
About us
Our Story
Leadership
Board of Directors
Scientific Advisory Board
Our Products
Sibnayal®
Other Products
R&D
Disease Focus Area
Distal Renal Tubular Acidosis (dRTA)
Cystinuria
Investors
Investor Relations
Management Team
Press Releases
Events & Presentations
Analyst Coverage
Stock Information
Financial Information
Investors FAQs
Contact Us
EN
FR
Advicenne France
Nous connaître
Qui sommes-nous ?
L’équipe de direction
Le conseil d’administration
Le conseil scientifique
Nos produits
Sibnayal®
Autres produits
R&D
Pathologies ciblées
Acidose Tubulaire Rénale distale (ATRd)
Cystinurie
Investisseurs
Relations Investisseurs
Équipe de direction
Communiqués de Presse
Événements & Présentations
Analystes
Action Advicenne
Information Financière
FAQ Investisseurs
Contact
EN
FR
Site France
Advicenne appoints Ludovic Robin as Chief Business & Strategy Officer
Sep 1, 2016
Advicenne appoints Ludovic Robin as Chief Business & Strategy Officer
September 1, 2016
Open file
Retour aux communiqués de presse
Back to press releases
Ouvrir le document
Open the file
